GlassScriptPhysician profile
Aaron D Kulwicki
NPI 1841238755
$23,426.21
in general payments reported to CMS, 2019-2025
36 companies · $2,406 in 2025
The $2,406 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,280 · 2020: $7,536 · 2021: $2,685 · 2022: $1,963 · 2023: $2,481 · 2024: $3,075 · 2025: $2,406.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,763 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,762.61 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,200.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $6,383.15 | 2019-2025 | Indigo System, Penumbra System, Ruby Coil |
| Abbott Laboratories | $3,592.29 | 2019-2025 | Esprit, Xact, Jeti |
| Bolton Medical INC | $2,646.04 | 2019-2025 | Treo Abdominal Stent-Graft System |
| Becton, Dickinson and Company | $2,450.00 | 2020 | |
| W. L. Gore & Associates, INC. | $1,889.64 | 2019-2025 | Gore Viabahn Vbx Balloon Expandable Endo, Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Excluder Iliac Branch Endoprosthesis |
| Bard Peripheral Vascular, INC. | $1,290.49 | 2019-2025 | Rotarexs 6 F X 135 Cm, Lutonix Drug Coated Balloon |
| Inari Medical, INC. | $752.11 | 2019-2022 | |
| Shockwave Medical, INC | $695.79 | 2020-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Boston Scientific Corporation | $487.40 | 2023-2024 | Eluvia |
| Cook Medical LLC | $367.35 | 2019-2022 | |
| Medtronic, INC. | $337.82 | 2023-2025 | Heli-Fx Endoanchor System |
| Angiodynamics, INC. | $253.50 | 2019-2024 | Angiovac |
| Ekos Corporation | $229.10 | 2019 | |
| Cardiovascular Systems INC. | $219.64 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $174.79 | 2019-2023 | Xarelto |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $165.82 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Shape Memory Medical INC. | $150.00 | 2024 | Impede Embolization Plug |
| Kerecis Limited | $149.75 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Philips North America LLC | $141.56 | 2020 | |
| Acera Surgical, INC. | $138.01 | 2024 | Restrata Wound Matrix |
| Reflow Medical INC | $126.83 | 2024 | |
| Paratek Pharmaceuticals, INC. | $125.01 | 2025 | Nuzyra |
| Portola Pharmaceuticals, LLC | $115.42 | 2019 | |
| Argon Medical Devices, INC. | $111.83 | 2021 | |
| Smith+Nephew, INC. | $91.78 | 2025 | Grafix Pl |
| Cardiva Medical, INC. | $56.26 | 2022-2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Thrombolex, INC. | $49.29 | 2023 | |
| Cvrx, INC. | $47.99 | 2025 | Barostim Neo System |
| Imperative Care, INC | $44.53 | 2024 | Symphony Catheter |
| Pfizer INC. | $39.96 | 2023-2024 | |
| Solventum Corporation | $26.40 | 2025 | Activ.A.C. |
| Medtronic Vascular, INC. | $19.81 | 2019 | |
| United Therapeutics Corporation | $17.65 | 2025 | Orenitram, Remodulin |
| Pacira Pharmaceuticals Incorporated | $13.59 | 2025 | Exparel |
| Kci USA, INC. | $12.96 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $12.65 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Kulwicki listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.